Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gram-Negative Bacterial Infections | 3 | 2026 | 101 | 2.030 |
Why?
|
| Gram-Negative Bacteria | 2 | 2026 | 76 | 1.830 |
Why?
|
| Muromegalovirus | 8 | 2016 | 12 | 1.430 |
Why?
|
| Bacteremia | 2 | 2026 | 433 | 1.420 |
Why?
|
| Anti-Bacterial Agents | 2 | 2026 | 2574 | 0.830 |
Why?
|
| Herpesviridae Infections | 4 | 2016 | 146 | 0.830 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2021 | 141 | 0.770 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2014 | 460 | 0.740 |
Why?
|
| Influenza B virus | 2 | 2023 | 102 | 0.690 |
Why?
|
| Influenza, Human | 3 | 2024 | 703 | 0.680 |
Why?
|
| Antigens, Viral | 2 | 2021 | 394 | 0.660 |
Why?
|
| Cytomegalovirus Infections | 4 | 2014 | 221 | 0.660 |
Why?
|
| False Positive Reactions | 1 | 2021 | 142 | 0.650 |
Why?
|
| Disease Notification | 1 | 2020 | 10 | 0.640 |
Why?
|
| Influenza A virus | 1 | 2021 | 142 | 0.620 |
Why?
|
| Encephalitis | 3 | 2014 | 123 | 0.550 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 295 | 0.510 |
Why?
|
| Pandemics | 3 | 2021 | 1112 | 0.510 |
Why?
|
| Microglia | 3 | 2014 | 146 | 0.500 |
Why?
|
| Vaccines | 1 | 2021 | 386 | 0.490 |
Why?
|
| Interleukin-10 | 4 | 2014 | 187 | 0.480 |
Why?
|
| Brain | 7 | 2016 | 3146 | 0.450 |
Why?
|
| B-Lymphocytes, Regulatory | 1 | 2014 | 2 | 0.440 |
Why?
|
| Murine Acquired Immunodeficiency Syndrome | 1 | 2013 | 1 | 0.400 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2013 | 13 | 0.400 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2013 | 501 | 0.390 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2026 | 848 | 0.380 |
Why?
|
| Herpes Simplex | 1 | 2013 | 59 | 0.380 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2013 | 134 | 0.370 |
Why?
|
| Seasons | 3 | 2024 | 332 | 0.370 |
Why?
|
| Virus Activation | 1 | 2012 | 87 | 0.350 |
Why?
|
| Immunity, Humoral | 1 | 2012 | 73 | 0.350 |
Why?
|
| Interferon-gamma | 3 | 2014 | 542 | 0.330 |
Why?
|
| Encephalitis, Viral | 1 | 2010 | 20 | 0.320 |
Why?
|
| Brucella melitensis | 2 | 2007 | 8 | 0.320 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 63 | 0.320 |
Why?
|
| Brucellosis | 2 | 2007 | 19 | 0.320 |
Why?
|
| Central Nervous System | 1 | 2012 | 269 | 0.310 |
Why?
|
| Immunologic Memory | 1 | 2011 | 194 | 0.310 |
Why?
|
| Neural Stem Cells | 1 | 2011 | 130 | 0.300 |
Why?
|
| Neurogenesis | 1 | 2011 | 210 | 0.290 |
Why?
|
| Influenza Vaccines | 2 | 2024 | 502 | 0.280 |
Why?
|
| Gram-Negative Anaerobic Bacteria | 1 | 2008 | 1 | 0.270 |
Why?
|
| Hemagglutination | 1 | 2008 | 7 | 0.270 |
Why?
|
| Siderophores | 1 | 2008 | 11 | 0.270 |
Why?
|
| Texas | 3 | 2021 | 3655 | 0.270 |
Why?
|
| Enzymes | 1 | 2008 | 44 | 0.270 |
Why?
|
| Bacterial Adhesion | 1 | 2008 | 104 | 0.260 |
Why?
|
| Mice, Inbred BALB C | 5 | 2014 | 979 | 0.250 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2007 | 22 | 0.250 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 2 | 2024 | 128 | 0.250 |
Why?
|
| Blood Culture | 1 | 2026 | 37 | 0.230 |
Why?
|
| Escherichia coli Infections | 1 | 2008 | 194 | 0.230 |
Why?
|
| Polymerase Chain Reaction | 3 | 2011 | 1453 | 0.230 |
Why?
|
| DNA, Bacterial | 1 | 2007 | 479 | 0.220 |
Why?
|
| Phenotype | 3 | 2026 | 4456 | 0.220 |
Why?
|
| Mice, Knockout | 5 | 2014 | 3810 | 0.220 |
Why?
|
| Prevalence | 3 | 2021 | 2687 | 0.210 |
Why?
|
| Escherichia coli | 2 | 2011 | 985 | 0.190 |
Why?
|
| Urinary Tract Infections | 1 | 2008 | 335 | 0.190 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2026 | 396 | 0.190 |
Why?
|
| Mice | 9 | 2016 | 18160 | 0.190 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2024 | 192 | 0.180 |
Why?
|
| Outpatients | 1 | 2024 | 262 | 0.180 |
Why?
|
| Bacterial Proteins | 1 | 2008 | 947 | 0.180 |
Why?
|
| Sepsis | 1 | 2026 | 494 | 0.180 |
Why?
|
| Antibodies, Viral | 3 | 2020 | 1171 | 0.170 |
Why?
|
| B-Lymphocytes | 2 | 2016 | 508 | 0.170 |
Why?
|
| NIH 3T3 Cells | 2 | 2012 | 91 | 0.170 |
Why?
|
| Device Approval | 1 | 2021 | 12 | 0.170 |
Why?
|
| Animals | 12 | 2016 | 33660 | 0.170 |
Why?
|
| Humans | 16 | 2026 | 130085 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 784 | 0.160 |
Why?
|
| Serologic Tests | 1 | 2020 | 123 | 0.160 |
Why?
|
| Epidemiological Monitoring | 1 | 2020 | 69 | 0.160 |
Why?
|
| Emergencies | 1 | 2021 | 170 | 0.150 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 287 | 0.150 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 2076 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 525 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 271 | 0.130 |
Why?
|
| Vaccination | 3 | 2024 | 1052 | 0.120 |
Why?
|
| Time Factors | 1 | 2026 | 6165 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 337 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 348 | 0.120 |
Why?
|
| Flow Cytometry | 3 | 2016 | 765 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2026 | 6402 | 0.110 |
Why?
|
| Female | 11 | 2024 | 70246 | 0.110 |
Why?
|
| Animals, Newborn | 3 | 2016 | 1019 | 0.100 |
Why?
|
| Neuroglia | 1 | 2016 | 219 | 0.100 |
Why?
|
| Immunophenotyping | 1 | 2014 | 332 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2014 | 194 | 0.100 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 235 | 0.100 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2014 | 143 | 0.100 |
Why?
|
| B7-H1 Antigen | 1 | 2014 | 133 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 6765 | 0.100 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 630 | 0.090 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 4639 | 0.090 |
Why?
|
| Virus Latency | 1 | 2012 | 65 | 0.090 |
Why?
|
| Plasma Cells | 1 | 2012 | 54 | 0.090 |
Why?
|
| Genes, MHC Class II | 1 | 2011 | 12 | 0.090 |
Why?
|
| Neurons | 2 | 2012 | 1978 | 0.090 |
Why?
|
| HIV Seropositivity | 1 | 2012 | 125 | 0.090 |
Why?
|
| Astrocytes | 1 | 2014 | 268 | 0.090 |
Why?
|
| Poultry Diseases | 1 | 2010 | 5 | 0.080 |
Why?
|
| India | 2 | 2012 | 231 | 0.080 |
Why?
|
| Cochlea | 1 | 2011 | 86 | 0.080 |
Why?
|
| Paramyxoviridae Infections | 1 | 2010 | 48 | 0.080 |
Why?
|
| Metapneumovirus | 1 | 2010 | 53 | 0.080 |
Why?
|
| Macrophages | 2 | 2011 | 659 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2016 | 2885 | 0.070 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2011 | 156 | 0.070 |
Why?
|
| Neutrophils | 1 | 2011 | 362 | 0.070 |
Why?
|
| Middle Aged | 4 | 2024 | 28314 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 636 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2011 | 823 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2012 | 376 | 0.070 |
Why?
|
| Inflammation | 2 | 2013 | 1478 | 0.070 |
Why?
|
| Virus Replication | 1 | 2011 | 607 | 0.070 |
Why?
|
| Mannose | 1 | 2008 | 25 | 0.070 |
Why?
|
| Brain Diseases | 1 | 2011 | 298 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 4691 | 0.070 |
Why?
|
| Urine | 1 | 2008 | 89 | 0.070 |
Why?
|
| Viral Vaccines | 1 | 2010 | 321 | 0.070 |
Why?
|
| Pruritus | 1 | 2007 | 51 | 0.060 |
Why?
|
| Zoonoses | 1 | 2007 | 52 | 0.060 |
Why?
|
| Endemic Diseases | 1 | 2007 | 60 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2009 | 351 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2011 | 905 | 0.060 |
Why?
|
| Virulence Factors | 1 | 2008 | 180 | 0.060 |
Why?
|
| Aged | 2 | 2024 | 20821 | 0.060 |
Why?
|
| Exanthema | 1 | 2007 | 73 | 0.060 |
Why?
|
| Adult | 4 | 2024 | 31011 | 0.060 |
Why?
|
| Endocarditis, Bacterial | 1 | 2006 | 127 | 0.060 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 405 | 0.050 |
Why?
|
| Rats | 1 | 2010 | 3372 | 0.050 |
Why?
|
| Feces | 1 | 2008 | 718 | 0.050 |
Why?
|
| Leukocytes | 2 | 2016 | 205 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 1205 | 0.050 |
Why?
|
| Male | 5 | 2024 | 64386 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2011 | 2462 | 0.050 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2022 | 7 | 0.050 |
Why?
|
| Calcifediol | 1 | 2022 | 13 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17541 | 0.040 |
Why?
|
| Vitamins | 1 | 2022 | 110 | 0.040 |
Why?
|
| Cytomegalovirus | 2 | 2014 | 258 | 0.040 |
Why?
|
| Biomarkers | 1 | 2011 | 3358 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 233 | 0.040 |
Why?
|
| Nucleocapsid Proteins | 1 | 2020 | 5 | 0.040 |
Why?
|
| Vitamin D | 1 | 2022 | 193 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2020 | 207 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 129 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 213 | 0.040 |
Why?
|
| United States | 2 | 2024 | 11896 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 781 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2016 | 59 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 928 | 0.030 |
Why?
|
| Neuroimmunomodulation | 1 | 2014 | 18 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 828 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 229 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2014 | 235 | 0.020 |
Why?
|
| Hepatitis C Antibodies | 1 | 2012 | 27 | 0.020 |
Why?
|
| HIV Antibodies | 1 | 2012 | 70 | 0.020 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2011 | 24 | 0.020 |
Why?
|
| Turkeys | 1 | 2010 | 3 | 0.020 |
Why?
|
| Mitogens | 1 | 2010 | 30 | 0.020 |
Why?
|
| Coinfection | 1 | 2012 | 186 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2548 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2010 | 75 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 1332 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 141 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 9981 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 780 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 1241 | 0.020 |
Why?
|
| L-Selectin | 1 | 2009 | 18 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2011 | 345 | 0.020 |
Why?
|
| Luciferases | 1 | 2009 | 126 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2009 | 52 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2011 | 409 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 13269 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2009 | 291 | 0.020 |
Why?
|
| Child | 2 | 2024 | 26174 | 0.020 |
Why?
|
| Spleen | 1 | 2009 | 258 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2024 | 15005 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 1319 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1592 | 0.020 |
Why?
|
| Adolescent | 1 | 2024 | 20800 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 2330 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 4645 | 0.010 |
Why?
|